期刊文献+

血液保护与免疫功能 被引量:4

下载PDF
导出
摘要 血液保护是指在围手术期采用或者联合应用各种技术保护和保存血液,以达到减少出血、少输血、不输血的目的[1]。恶性肿瘤患者存在着不同程度免疫监控能力降低和免疫功能的抑制,麻醉、手术和术中异体输血又加重免疫功能的抑制,使术后感染和肿瘤细胞生长、转移的机会增加。近年来,临床用血量日益增长,而血源有限。
出处 《江西医药》 CAS 2013年第1期82-85,共4页 Jiangxi Medical Journal
关键词 血液保护 免疫
  • 相关文献

参考文献3

二级参考文献22

  • 1田婕,徐建国.羟乙基淀粉的研究进展[J].医学研究生学报,2004,17(10):942-945. 被引量:4
  • 2唐琦峰,钱燕宁,季晓辉.输血与免疫抑制[J].中国综合临床,2004,20(12):1149-1151. 被引量:6
  • 3盛洪广,罗振中,陈受琳,周志东,左恒,徐国海.急性高容量血液稀释对硬膜外阻滞复合全麻手术病人血液动力学的影响[J].临床麻醉学杂志,2005,21(6):430-432. 被引量:17
  • 4张立天,姚咏明,陆家齐,于燕.腹部大手术后杀菌/通透性增加蛋白的变化规律及意义[J].解放军医学杂志,2007,32(4):377-379. 被引量:2
  • 5Avall A, Hyllner M, Bengtson J P, et al. Postoperative inflammatory response after autologous and allogeneic blood transfusion[J]. Anesthesiol, 1997, 87: 511-514.
  • 6Ooi CE,Weiss J,Levy O,et al.Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins[J].J Biol Chem,1990,265 (26):15956-15962.
  • 7Lin Y,Leach WJ,Ammons WS.Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis[J].Antimicrob Agents Chemother,1996,40(1):65-69.
  • 8Schultz H,Weiss J,Carroll SF,et al.The endotoxin-binding bactericidal/permeability-increasing protein (BPI):a target antigen of autoantibodies[J].J Leukoc Biol,2001,69 (4):505-512.
  • 9Tian J,Lin X,Zhou W,et al.Hydroxyethyl starch inhibits NF-kappaB activation and prevents the expression of inflammatory mediators in endotoxic rats[J].Ann Clin Lab Sci,2003,33(4):451-458.
  • 10P attanpa nyasatK,Ky leDE,TongtaweP,eta1.Flowcytometricimmunophenotypingoflymphocytesubsetsinsamplesthatcontainahighp roportionofnonlymphoidcells[].Cytometry.1994

共引文献32

同被引文献28

  • 1张传仓,朱为国,封志纯.地中海贫血患儿输血后神经系统并发症1例[J].广东医学,2004,25(8):992-992. 被引量:5
  • 2骆群,刘景汉.输血引起的免疫排斥、耐受与抑制[J].临床输血与检验,2005,7(2):152-154. 被引量:12
  • 3Hayden S J, Albert TJ, Watkins TR, et al. Anemia in critical illness: insights into etiology,consequences,and management [J]. Am J Respir Crit Care Med,2012,185 : 1049-1057.
  • 4Corwin,HL. ,KC. Parsonnet and A. Gettinger,RBC transfusion in the ICU. Is there a reason?[J]. Chest, 1995,108(3) :767-771.
  • 5Corwin,HL,SB,Krantz,Anemia of the critically ill: "acute" anemia of chronic disease[J]. Crit Care Med, 2000,28(8) ; 3098-3099.
  • 6Dong A. Synergistic effect of anemia and red blood cells transfusion on inflammation and lung injury [J]. Adv Hematol,2012. 2012: 924042.
  • 7Vamvakas EC. Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results?[J]. Vox Sang,2007,93(3) : 196-207.
  • 8Carson JL,et al. Red blood cell transfusion:a clinical practice guideline from the AABB. Ann Intern Med,2012. 157(1):49-58.
  • 9Hrbert PC ,Wells G, Blajchman MA ,et al. A multicenter,random- ized,controlled clinical trial of transfusion requirements in critical care[J]. N Engi Meal, 1999,340:409-417.
  • 10Hebert PC. A multieenter,randomized,eontrolled clinical trial of transfusion requirements in critical care [J]. N Engl J Med,!999, 340(6) :409-17.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部